Skip to content
Screener

Free cash flow at other companies

Eli Lilly logo
Eli LillyLLY
$7.76B+458%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-$18.07M-14.5%
Immunome logo
ImmunomeIMNM
-$63.87M-27.0%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$89.87M+13.5%
uniQure logo
uniQureQURE
-$29.05M+27.7%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$44.36M-6.3%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$29.3M-21.7%
Net income-$26.8M-24.7%
EPS (diluted)-$0.22+24.1%

Balance sheet

See full
Cash & equivalents$48.5M+68.1%
Total debt$3.9M+11.1%
Total equity$323.9M+21.9%
Total assets$392.0M+26.2%

Cash flow

See full
Operating cash flow-$20.7M-3.5%
CapEx$14.2M+1,284%

Valuation

See full
Market cap$342.14M+25.3%
Enterprise value$297.56M+20.1%

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp

Returns & leverage

See full
Return on equity-39.5%+14.0pp
Debt / equity0.0×
Current ratio6.6×-8.5×

Where this comes from

Calculated from Perspective Therapeutics’s reported figures.

The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026. Open the filing →

Filed
Aug 10, 2026, 4:34 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342512

FAQ

What is Perspective Therapeutics's free cash flow?
Perspective Therapeutics (CATX) reported free cash flow of -$34.85M in Q2 2026.
How has Perspective Therapeutics's free cash flow changed year-over-year?
Perspective Therapeutics's free cash flow decreased by 66.1% year-over-year, from -$20.98M to -$34.85M.
What is the long-term trend for Perspective Therapeutics's free cash flow?
Over 2 years (2023 to 2025), Perspective Therapeutics's free cash flow has grown at a 58.3% compound annual growth rate (CAGR), from -$37.99M to -$95.23M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about Perspective Therapeutics's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude